乳腺癌耐药-话题@MedSci - 梅斯（MedSci）

#乳腺癌耐药#

7篇内容 | 692人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1797822, encodeId=aca91e978222a, content=<a href='/topic/show?id=555523e73fc' target=_blank style='color:#2F92EE;'>#乳腺癌耐药#</a>, objectTitle=英国癌症研究所调控细胞分裂的MPS1新型抑制剂具有克服侵袭性乳腺癌耐药的潜力, objectType=article, longId=180631, objectId=5251180631e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5251180631e6, replyNumber=0, likeNumber=66, createdTime=2019-12-08, rootId=0, userName=Homburg, userId=e87d405, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5251180631e6, moduleTitle=英国癌症研究所调控细胞分裂的MPS1新型抑制剂具有克服侵袭性乳腺癌耐药的潜力, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=5251180631e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1797821, encodeId=cd011e9782115, content=<a href='/topic/show?id=555523e73fc' target=_blank style='color:#2F92EE;'>#乳腺癌耐药#</a>, objectTitle=三阴性乳腺癌耐药是可逆的！靶向药物正在临床试验中, objectType=article, longId=165735, objectId=c179165e35b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c179165e35b0, replyNumber=0, likeNumber=71, createdTime=2019-06-03, rootId=0, userName=Homburg, userId=e87d405, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c179165e35b0, moduleTitle=三阴性乳腺癌耐药是可逆的！靶向药物正在临床试验中, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c179165e35b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1797820, encodeId=1e521e978206d, content=<a href='/topic/show?id=555523e73fc' target=_blank style='color:#2F92EE;'>#乳腺癌耐药#</a>, objectTitle=Pharmaceut Res：乳腺癌耐药蛋白（BCRP / ABCG2）在人源性远端肺上皮细胞中的表达及活性, objectType=article, longId=125690, objectId=6ae512569073, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ae512569073, replyNumber=0, likeNumber=72, createdTime=2018-03-31, rootId=0, userName=Homburg, userId=e87d405, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ae512569073, moduleTitle=Pharmaceut Res：乳腺癌耐药蛋白（BCRP / ABCG2）在人源性远端肺上皮细胞中的表达及活性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=6ae512569073)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1797819, encodeId=1ac01e9781923, content=<a href='/topic/show?id=555523e73fc' target=_blank style='color:#2F92EE;'>#乳腺癌耐药#</a>, objectTitle=Cancer Res：纳米药物新组合有望解决乳腺癌耐药问题, objectType=article, longId=71642, objectId=edace1642a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=edace1642a6, replyNumber=0, likeNumber=69, createdTime=2016-07-17, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=edace1642a6, moduleTitle=Cancer Res：纳米药物新组合有望解决乳腺癌耐药问题, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=edace1642a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1797818, encodeId=cabc1e9781839, content=<a href='/topic/show?id=555523e73fc' target=_blank style='color:#2F92EE;'>#乳腺癌耐药#</a>, objectTitle=Nat Rev Cancer：乳腺癌耐药机制新发现, objectType=article, longId=29515, objectId=3dd42951539, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3dd42951539, replyNumber=0, likeNumber=84, createdTime=2014-12-29, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3dd42951539, moduleTitle=Nat Rev Cancer：乳腺癌耐药机制新发现, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3dd42951539)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1797817, encodeId=878a1e978174e, content=<a href='/topic/show?id=555523e73fc' target=_blank style='color:#2F92EE;'>#乳腺癌耐药#</a>, objectTitle=Nat Gene：科学家破解乳腺癌耐药性机理, objectType=article, longId=27263, objectId=0a162e263c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a162e263c2, replyNumber=0, likeNumber=92, createdTime=2014-07-09, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a162e263c2, moduleTitle=Nat Gene：科学家破解乳腺癌耐药性机理, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0a162e263c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1797816, encodeId=1b171e9781627, content=<a href='/topic/show?id=555523e73fc' target=_blank style='color:#2F92EE;'>#乳腺癌耐药#</a>, objectTitle=Nature：雌激素受体改变“工作路线”致乳腺癌耐药, objectType=article, longId=3759, objectId=1dad3e599a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1dad3e599a, replyNumber=0, likeNumber=75, createdTime=2012-05-22, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1dad3e599a, moduleTitle=Nature：雌激素受体改变“工作路线”致乳腺癌耐药, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1dad3e599a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

乳腺癌耐药

2020-05-29

Homburg (审核中...)

前往app查看评论内容

#乳腺癌耐药#

英国癌症研究所调控细胞分裂的MPS1新型抑制剂具有克服侵袭性乳腺癌耐药的潜力

2019-12-08

Homburg (审核中...)

前往app查看评论内容

#乳腺癌耐药#

三阴性乳腺癌耐药是可逆的！靶向药物正在临床试验中

2019-06-03

Homburg (审核中...)

前往app查看评论内容

#乳腺癌耐药#

Pharmaceut Res：乳腺癌耐药蛋白（BCRP / ABCG2）在人源性远端肺上皮细胞中的表达及活性

2018-03-31

仁者大医 (审核中...)

前往app查看评论内容

#乳腺癌耐药#

Cancer Res：纳米药物新组合有望解决乳腺癌耐药问题

2016-07-17

仁者大医 (审核中...)

前往app查看评论内容

#乳腺癌耐药#

Nat Rev Cancer：乳腺癌耐药机制新发现

2014-12-29

仁者大医 (审核中...)

前往app查看评论内容

#乳腺癌耐药#

Nat Gene：科学家破解乳腺癌耐药性机理

2014-07-09

仁者大医 (审核中...)

前往app查看评论内容

#乳腺癌耐药#

Nature：雌激素受体改变“工作路线”致乳腺癌耐药

2012-05-22

科室
- - 订阅+
  - 更多科室
工具
服务